Our findings suggest that individuals with P/PLVs in the MLH1 gene in our African population could benefit from frequent cancer surveillance, particularly for colorectal, endometrial, and breast cancers as these were the most common cancers in this group. This evidence concerns the gene MLH1 and breast cancer.